MEDXF (Medexus Pharmaceuticals) Inventory Turnover: 0.35 (As of Mar. 2026)

What is Medexus Pharmaceuticals Inventory Turnover?

Medexus Pharmaceuticals MEDXF +0.70% 58 Inventory Turnover is 0.35 as of Mar. 2026. GuruFocus rates MEDXF with a GF Score™ of 58/100 and a GF Value™ of $1.32 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Medexus Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2026 was $11.38 Mil. Medexus Pharmaceuticals's Average Total Inventories for the quarter that ended in Mar. 2026 was $32.30 Mil. Medexus Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.35.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Medexus Pharmaceuticals's Days Inventory for the three months ended in Mar. 2026 was 258.98.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Medexus Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.31.

Medexus Pharmaceuticals (OTCPK:MEDXF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Medexus Pharmaceuticals's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	32.2985	/	11.38	*	365 / 4
	=	258.98

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Medexus Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	32.2985	/	24.652
	=	1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Medexus Pharmaceuticals Inventory Turnover Related Terms

Medexus Pharmaceuticals Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Medexus Pharmaceuticals's Inventory Turnover can be seen below:

Medexus Pharmaceuticals Inventory Turnover Chart

Medexus Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Inventory Turnover

Get a 7-Day Free Trial

2.15

2.17

2.00

1.57

1.31

Medexus Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.36	0.31	0.31	0.36	0.35

58GF Score

Medexus Pharmaceuticals Inc MEDXF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medexus Pharmaceuticals Inventory Turnover Calculation

Medexus Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Mar. 2026 is calculated as

	Inventory Turnover (A: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Mar. 2026 )	/ (	(Total Inventories (A: Mar. 2025 )	+	Total Inventories (A: Mar. 2026 ))	/	count )
=	44.922	/ (	(35.29	+	33.3)	/	2 )
=	44.922	/	34.295
=	1.31

Medexus Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	11.38	/ (	(31.297	+	33.3)	/	2 )
=	11.38	/	32.2985
=	0.35

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.35 mean?

Medexus Pharmaceuticals (MEDXF) has a Inventory Turnover of 0.35 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Medexus Pharmaceuticals and its competitors.

Is Medexus Pharmaceuticals' Inventory Turnover too high?

Medexus Pharmaceuticals' current Inventory Turnover is 0.35. Overall, Medexus Pharmaceuticals has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Medexus Pharmaceuticals' Inventory Turnover compare to ZTS and UTHR?

Medexus Pharmaceuticals' Inventory Turnover of 0.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Medexus Pharmaceuticals and its competitors. Medexus Pharmaceuticals's current Inventory Turnover is 0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medexus Pharmaceuticals stock overvalued right now?

Based on GuruFocus' analysis, Medexus Pharmaceuticals (MEDXF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.32, compared to a current price of $3.58 — trading 170.8% above its estimated fair value. The current Inventory Turnover is 0.35. Medexus Pharmaceuticals' overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Medexus Pharmaceuticals (MEDXF), the current Inventory Turnover is 0.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medexus Pharmaceuticals (MEDXF) Overvalued in 2026?

Based on GuruFocus' analysis, Medexus Pharmaceuticals stock appears to be overvalued. The current stock price of $3.58 is trading 170.8% above its estimated GF Value™ of $1.32. GuruFocus considers Medexus Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for MEDXF:

Inventory Turnover: 0.35
GF Value™: $1.32 vs. price of $3.58 (170.8% above fair value)
GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the MEDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medexus Pharmaceuticals Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XCNQ:JUSH XCNQ:AAWH.U TSX:HLS XCNQ:GRIN TSX:CWEB TSXV:RX XCNQ:NVRS TSX:LOVE TSX:CRDL TSXV:DB XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges P731:Germany MDP:Canada

Address 10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3

Website https://www.medexus.com

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Medexus products are generally sold in North America to wholesalers, distributors, government agencies, healthcare facilities and specialty pharmacies.

58GF Score

Get the complete analysis for MEDXF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.58

Price

$1.32

GF Value

View MEDXF Analysis

See Inventory Turnover data for all stocks →